10-Q Filing

ALKERMES PLC. CIK: 1520262 Q3 2017

Filing Information

Form Type	10-Q
Accession Number	`0001520262-17-000045`
Period End Date	20170930
Filing Date	20171026
Fiscal Year	2017
Fiscal Period	Q3
XBRL Instance	alks-20170930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 92 Cash Flow Statement 62 Comprehensive Income 4

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Preferred stock shares, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock shares, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock shares, authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Preferred stock shares, authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$181.11M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$202.24M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$186.38M	USD	Point-in-time
Preferred stock shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$165.12M	USD	Point-in-time
Preferred stock shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Investments - short-term	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$284.98M	USD	Point-in-time
Preferred stock shares, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock shares, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Investments - short-term	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$310.86M	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$207.54M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$191.10M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	450.00M	shares	Point-in-time
Inventory	`InventoryNet`	$85.03M	USD	Point-in-time
Inventory	`InventoryNet`	$63.00M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	450.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$39.34M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	155.79M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$38.89M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	154.19M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	153.75M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	152.43M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$781.55M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$790.68M	USD	Point-in-time
Treasury stock shares	`TreasuryStockCommonShares`	2.05M	shares	Point-in-time
INTANGIBLE ASSETS - NET	`IntangibleAssetsNetExcludingGoodwill`	$271.81M	USD	Point-in-time
INTANGIBLE ASSETS - NET	`IntangibleAssetsNetExcludingGoodwill`	$318.23M	USD	Point-in-time
Treasury stock shares	`TreasuryStockCommonShares`	1.76M	shares	Point-in-time
PROPERTY, PLANT AND EQUIPMENT, NET	`PropertyPlantAndEquipmentNet`	$264.79M	USD	Point-in-time
PROPERTY, PLANT AND EQUIPMENT, NET	`PropertyPlantAndEquipmentNet`	$270.67M	USD	Point-in-time
INVESTMENTS - LONG-TERM	`MarketableSecuritiesNoncurrent`	$121.93M	USD	Point-in-time
INVESTMENTS - LONG-TERM	`MarketableSecuritiesNoncurrent`	$118.75M	USD	Point-in-time
GOODWILL	`Goodwill`	$92.87M	USD	Point-in-time
GOODWILL	`Goodwill`	$92.87M	USD	Point-in-time
CONTINGENT CONSIDERATION	`BusinessCombinationContingentConsiderationAssetNoncurrent`	$63.20M	USD	Point-in-time
CONTINGENT CONSIDERATION	`BusinessCombinationContingentConsiderationAssetNoncurrent`	$79.10M	USD	Point-in-time
DEFERRED TAX ASSETS	`DeferredTaxAssetsGrossNoncurrent`	$47.77M	USD	Point-in-time
DEFERRED TAX ASSETS	`DeferredTaxAssetsGrossNoncurrent`	$117.45M	USD	Point-in-time
OTHER ASSETS	`OtherAssetsNoncurrent`	$16.12M	USD	Point-in-time
OTHER ASSETS	`OtherAssetsNoncurrent`	$26.96M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.73B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.75B	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$207.06M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$251.19M	USD	Point-in-time
Long-term debt - short-term	`LongTermDebtCurrent`	$3.00M	USD	Point-in-time
Long-term debt - short-term	`LongTermDebtCurrent`	$3.00M	USD	Point-in-time
Deferred revenue - short-term	`DeferredRevenueCurrent`	$1.94M	USD	Point-in-time
Deferred revenue - short-term	`DeferredRevenueCurrent`	$1.83M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$211.99M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$256.01M	USD	Point-in-time
LONG-TERM DEBT	`LongTermDebtNoncurrent`	$280.67M	USD	Point-in-time
LONG-TERM DEBT	`LongTermDebtNoncurrent`	$278.99M	USD	Point-in-time
OTHER LONG-TERM LIABILITIES	`OtherLiabilitiesNoncurrent`	$17.16M	USD	Point-in-time
OTHER LONG-TERM LIABILITIES	`OtherLiabilitiesNoncurrent`	$19.91M	USD	Point-in-time
DEFERRED REVENUE - LONG-TERM	`DeferredRevenueNoncurrent`	$6.13M	USD	Point-in-time
DEFERRED REVENUE - LONG-TERM	`DeferredRevenueNoncurrent`	$7.12M	USD	Point-in-time
Total liabilities	`Liabilities`	$516.94M	USD	Point-in-time
Total liabilities	`Liabilities`	$561.05M	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred shares, par value, $0.01 per share; 50,000,000 shares authorized; zero issued and outstanding at September 30, 2017 and December 31, 2016, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred shares, par value, $0.01 per share; 50,000,000 shares authorized; zero issued and outstanding at September 30, 2017 and December 31, 2016, respectively	`PreferredStockValue`	-	USD	Point-in-time
Ordinary shares, par value, $0.01 per share; 450,000,000 shares authorized; 155,793,163 and 154,191,281 shares issued; 153,745,656 and 152,430,514 shares outstanding at September 30, 2017, and December 31, 2016, respectively	`CommonStockValue`	$1.55M	USD	Point-in-time
Ordinary shares, par value, $0.01 per share; 450,000,000 shares authorized; 155,793,163 and 154,191,281 shares issued; 153,745,656 and 152,430,514 shares outstanding at September 30, 2017, and December 31, 2016, respectively	`CommonStockValue`	$1.54M	USD	Point-in-time
Treasury shares, at cost (2,047,507 and 1,760,767 shares at September 30, 2017 and December 31, 2016, respectively)	`TreasuryStockCommonValue`	$72.64M	USD	Point-in-time
Treasury shares, at cost (2,047,507 and 1,760,767 shares at September 30, 2017 and December 31, 2016, respectively)	`TreasuryStockCommonValue`	$89.31M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.23B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.31B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.25M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.27M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-947.94M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.03B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$1.21B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$1.19B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$1.73B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$1.75B	USD	Point-in-time

Income Statement 92 line items

Line Item	Tag	Value	Unit	Period
Manufacturing and royalty revenues	`ManufacturingAndRoyaltyRevenues`	$353.44M	USD	3 Qtrs
Manufacturing and royalty revenues	`ManufacturingAndRoyaltyRevenues`	$110.25M	USD	1 Quarter
Manufacturing and royalty revenues	`ManufacturingAndRoyaltyRevenues`	$366.61M	USD	3 Qtrs
Manufacturing and royalty revenues	`ManufacturingAndRoyaltyRevenues`	$122.68M	USD	1 Quarter
Product sales, net	`SalesRevenueGoodsNet`	$93.68M	USD	1 Quarter
Product sales, net	`SalesRevenueGoodsNet`	$69.80M	USD	1 Quarter
Product sales, net	`SalesRevenueGoodsNet`	$258.89M	USD	3 Qtrs
Product sales, net	`SalesRevenueGoodsNet`	$176.69M	USD	3 Qtrs
Research and development revenue	`ContractsRevenue`	$1.03M	USD	1 Quarter
Research and development revenue	`ContractsRevenue`	$189.00K	USD	1 Quarter
Research and development revenue	`ContractsRevenue`	$2.50M	USD	3 Qtrs
Research and development revenue	`ContractsRevenue`	$2.04M	USD	3 Qtrs
Total revenues	`SalesRevenueNet`	$180.24M	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$532.18M	USD	3 Qtrs
Total revenues	`SalesRevenueNet`	$217.38M	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$628.00M	USD	3 Qtrs
Cost of goods manufactured and sold (exclusive of amortization of acquired intangible assets shown below)	`CostOfGoodsSold`	$116.24M	USD	3 Qtrs
Cost of goods manufactured and sold (exclusive of amortization of acquired intangible assets shown below)	`CostOfGoodsSold`	$35.46M	USD	1 Quarter
Cost of goods manufactured and sold (exclusive of amortization of acquired intangible assets shown below)	`CostOfGoodsSold`	$97.17M	USD	3 Qtrs
Cost of goods manufactured and sold (exclusive of amortization of acquired intangible assets shown below)	`CostOfGoodsSold`	$36.05M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$99.44M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$297.52M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$104.41M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$308.40M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$310.68M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$99.63M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$91.14M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$276.99M	USD	3 Qtrs
Amortization of acquired intangible assets	`AmortizationOfIntangibleAssets`	$15.32M	USD	1 Quarter
Amortization of acquired intangible assets	`AmortizationOfIntangibleAssets`	$46.42M	USD	3 Qtrs
Amortization of acquired intangible assets	`AmortizationOfIntangibleAssets`	$45.64M	USD	3 Qtrs
Amortization of acquired intangible assets	`AmortizationOfIntangibleAssets`	$15.64M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$717.31M	USD	3 Qtrs
Total expenses	`CostsAndExpenses`	$781.74M	USD	3 Qtrs
Total expenses	`CostsAndExpenses`	$255.74M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$241.37M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-61.13M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-38.36M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-153.74M	USD	3 Qtrs
OPERATING LOSS	`OperatingIncomeLoss`	$-185.13M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$3.29M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$2.92M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$912.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.17M	USD	1 Quarter
Interest expense	`InterestExpense`	$3.13M	USD	1 Quarter
Interest expense	`InterestExpense`	$3.38M	USD	1 Quarter
Interest expense	`InterestExpense`	$8.82M	USD	3 Qtrs
Interest expense	`InterestExpense`	$9.99M	USD	3 Qtrs
Change in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$15.90M	USD	3 Qtrs
Change in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$13.60M	USD	1 Quarter
Change in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$3.10M	USD	3 Qtrs
Change in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-1.00M	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-752.00K	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-970.00K	USD	3 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-10.70M	USD	3 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	$-9.08M	USD	1 Quarter
Total other (expense) income, net	`NonoperatingIncomeExpense`	$-4.21M	USD	1 Quarter
Total other (expense) income, net	`NonoperatingIncomeExpense`	$2.57M	USD	1 Quarter
Total other (expense) income, net	`NonoperatingIncomeExpense`	$-325.00K	USD	3 Qtrs
Total other (expense) income, net	`NonoperatingIncomeExpense`	$-4.95M	USD	3 Qtrs
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-154.06M	USD	3 Qtrs
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-35.79M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-65.34M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-190.07M	USD	3 Qtrs
INCOME TAX (BENEFIT) PROVISION	`IncomeTaxExpenseBenefit`	$-2.65M	USD	1 Quarter
INCOME TAX (BENEFIT) PROVISION	`IncomeTaxExpenseBenefit`	$-5.90M	USD	3 Qtrs
INCOME TAX (BENEFIT) PROVISION	`IncomeTaxExpenseBenefit`	$-2.77M	USD	3 Qtrs
INCOME TAX (BENEFIT) PROVISION	`IncomeTaxExpenseBenefit`	$486.00K	USD	1 Quarter
NET LOSS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-62.69M	USD	1 Quarter
NET LOSS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-148.16M	USD	3 Qtrs
NET LOSS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-187.30M	USD	3 Qtrs
NET LOSS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-36.28M	USD	1 Quarter
Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.24	USD	1 Quarter
Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.41	USD	1 Quarter
Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.24	USD	3 Qtrs
Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.97	USD	3 Qtrs
Basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	151.26M	shares	3 Qtrs
Basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	153.26M	shares	3 Qtrs
Basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	151.65M	shares	1 Quarter
Basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	153.68M	shares	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-62.69M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-148.16M	USD	3 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-187.30M	USD	3 Qtrs
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-36.28M	USD	1 Quarter
Holding gain (loss), net of a tax (benefit) provision of $35, $(129), $(14) and $445, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-261.00K	USD	1 Quarter
Holding gain (loss), net of a tax (benefit) provision of $35, $(129), $(14) and $445, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$988.00K	USD	3 Qtrs
Holding gain (loss), net of a tax (benefit) provision of $35, $(129), $(14) and $445, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$22.00K	USD	3 Qtrs
Holding gain (loss), net of a tax (benefit) provision of $35, $(129), $(14) and $445, respectively	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$83.00K	USD	1 Quarter
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-62.95M	USD	1 Quarter
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-36.19M	USD	1 Quarter
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-186.31M	USD	3 Qtrs
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-148.13M	USD	3 Qtrs

Cash Flow Statement 62 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-148.16M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-187.30M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$73.31M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$69.61M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$74.61M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$63.34M	USD	3 Qtrs
Impairment of investment in Reset Therapeutics, Inc.	`EquityMethodInvestmentOtherThanTemporaryImpairment`	$10.47M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-12.54M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-11.92M	USD	3 Qtrs
Excess tax benefit from share-based compensation	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$5.12M	USD	3 Qtrs
Change in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$15.90M	USD	3 Qtrs
Change in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$13.60M	USD	1 Quarter
Change in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$3.10M	USD	3 Qtrs
Change in the fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-1.00M	USD	1 Quarter
Other non-cash charges	`OtherNoncashExpense`	$1.90M	USD	3 Qtrs
Other non-cash charges	`OtherNoncashExpense`	$3.36M	USD	3 Qtrs
Receivables	`IncreaseDecreaseInReceivables`	$21.96M	USD	3 Qtrs
Receivables	`IncreaseDecreaseInReceivables`	$16.43M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$17.16M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$21.84M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesAndOtherAssets`	$1.94M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesAndOtherAssets`	$1.11M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$43.43M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$26.83M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-1.10M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-526.00K	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$4.51M	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$6.68M	USD	3 Qtrs
Cash flows used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-71.36M	USD	3 Qtrs
Cash flows used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-16.72M	USD	3 Qtrs
Additions of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$33.48M	USD	3 Qtrs
Additions of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$33.79M	USD	3 Qtrs
Proceeds from the sale of equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$50.00K	USD	3 Qtrs
Proceeds from the sale of equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$100.00K	USD	3 Qtrs
Investment in Reset Therapeutics, Inc.	`PaymentsToAcquireEquityMethodInvestments`	$15.00M	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$289.23M	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$296.71M	USD	3 Qtrs
Sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$493.52M	USD	3 Qtrs
Sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$318.49M	USD	3 Qtrs
Cash flows (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$148.12M	USD	3 Qtrs
Cash flows (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-4.17M	USD	3 Qtrs
Proceeds from the issuance of ordinary shares under share-based compensation arrangements	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$18.30M	USD	3 Qtrs
Proceeds from the issuance of ordinary shares under share-based compensation arrangements	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$12.75M	USD	3 Qtrs
Excess tax benefit from share-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$5.12M	USD	3 Qtrs
Employee taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$8.43M	USD	3 Qtrs
Employee taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$16.42M	USD	3 Qtrs
Principal payments of long-term debt	`RepaymentsOfLongTermDebt`	$2.25M	USD	3 Qtrs
Principal payments of long-term debt	`RepaymentsOfLongTermDebt`	$65.06M	USD	3 Qtrs
Cash flows used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-370.00K	USD	3 Qtrs
Cash flows used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-55.63M	USD	3 Qtrs
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$21.13M	USD	3 Qtrs
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-21.25M	USD	3 Qtrs
CASH AND CASH EQUIVALENTS - Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$165.12M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$202.24M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$181.11M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$186.38M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - End of period	`CashAndCashEquivalentsAtCarryingValue`	$165.12M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - End of period	`CashAndCashEquivalentsAtCarryingValue`	$202.24M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - End of period	`CashAndCashEquivalentsAtCarryingValue`	$181.11M	USD	Point-in-time
CASH AND CASH EQUIVALENTS - End of period	`CashAndCashEquivalentsAtCarryingValue`	$186.38M	USD	Point-in-time
Purchased capital expenditures included in accounts payable and accrued expenses	`NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1`	$3.64M	USD	3 Qtrs
Purchased capital expenditures included in accounts payable and accrued expenses	`NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1`	$5.32M	USD	3 Qtrs

Comprehensive Income 4 line items

Line Item	Tag	Value	Unit	Period
Tax (benefit) provision	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-129.00K	USD	1 Quarter
Tax (benefit) provision	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-14.00K	USD	3 Qtrs
Tax (benefit) provision	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$35.00K	USD	1 Quarter
Tax (benefit) provision	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$445.00K	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.